News

Astec Lifesciences announced that the 32th Annual General Meeting(AGM) of the company will be held on 31 July 2026.

Net Loss of Astec Lifesciences reported to Rs 7.76 crore in the quarter ended March 2026 as against net loss of Rs 16.09 crore during the previous quarter ended March 2025. Sales rose 32.70% to Rs 158.62 crore in the quarter ended March 2026 as against Rs 119.53 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 80.92 crore in the year ended March 2026 as against net loss of Rs 134.75 crore during the previous year ended March 2025. Sales rose 17.53% to Rs 448.15 crore in the year ended March 2026 as against Rs 381.30 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales158.62119.53 33 448.15381.30 18 OPM %5.774.63 --1.01-17.36 - PBDT3.87-4.08 LP -33.99-97.27 65 PBT-7.90-15.66 50 -78.91-140.99 44 NP-7.76-16.09 52 -80.92-134.75 40 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 27 April 2026.

Net Loss of Astec Lifesciences reported to Rs 15.70 crore in the quarter ended December 2025 as against net loss of Rs 40.38 crore during the previous quarter ended December 2024. Sales rose 32.88% to Rs 124.72 crore in the quarter ended December 2025 as against Rs 93.86 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales124.7293.86 33 OPM %3.19-6.12 - PBDT-2.37-13.75 83 PBT-13.59-25.15 46 NP-15.70-40.38 61 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live News